In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and ...

PETACH TIKVA, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in ...

Nanox Imaging Ltd. announced promising results from a clinical study showcasing its Nanox.ARC digital tomosynthesis system, which enhances musculoskeletal imaging and outperforms conventional ...

Nano-X Imaging shares were up 10%, to $6.61, after the company said it has received CE mark certification to market its multi-source Nanox.ARC system, including the Nanox.CLOUD, its accompanying cloud ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S. New clinical data supporting use of Nanox ...

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography. In addition ...

Nano-X Imaging (NASDAQ:NNOX) received CE mark certification to market the Nanox.ARC system, including the Nanox.CLOUD, its accompanying cloud-based infrastructure.  The company said new clinical data ...